|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/436 | |
| A61K 31/5377 | |||
| A61K 45/06 | |||
| A61P 35/00 |
| (11) | Patento numeris | 2370076 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 09756528.7 |
| Europos patento paraiškos padavimo data | 2009-11-25 | |
| (97) | Europos patento paraiškos paskelbimo data | 2011-10-05 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-01-04 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2009/065858 |
| Data | 2009-11-25 |
| (87) | Numeris | WO 2010/060937 |
| Data | 2010-06-03 |
| (30) | Numeris | Data | Šalis |
| 08170279 | 2008-11-28 | EP | |
| 08170287 | 2008-11-28 | EP | |
| 08170230 | 2008-11-28 | EP | |
| 08170246 | 2008-11-28 | EP |
| (72) |
JENSEN, Michael, Rugaard, CH
GARCIA-ECHEVERRIA, Carlos, CH
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | Pharmaceutical combination comprising a Hsp 90 inhibitor and a mTOR inhibitor |
| Pharmaceutical combination comprising a Hsp 90 inhibitor and a mTOR inhibitor |